Hope is on the horizon for patients with aggressive and inherited breast cancers. A recent clinical trial, led by researchers at Cambridge University, explored the effects of a combination of chemotherapy with Olaparib target cancer drug before surgery. Each patient who received this protocol survived the critical period after treatment. BRCA cancers are notoriously aggressive […]